Currently Enrolling

MARITIME-HF

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity/Overweight

Trial Overview

Clinical Area: Heart Failure with Preserved Ejection Fraction (HFpEF) or with mildly reduced Ejection Fraction (HFmrEF)
Condition: Heart Failure, Obesity
Trial Identifiers:
Locations:
  • Shenton House Joondalup, Perth
  • Leabrook, Adelaide
  • Wesley Testing Centre Milton, Brisbane
  • Mulgrave, Melbourne

Register Your Interest

Complete the form and a member of our Research & Clinical Trials team will be in touch.

Participate in Ongoing Clinical Trials

Eligible patients may have access to new cardiovascular treatments, monitoring technologies, and research programs through the Advara HeartCare network.







    Your information is kept confidential and used only for trial matching.